Supriya Lifescience Ltd
NSE:SUPRIYA

Watchlist Manager
Supriya Lifescience Ltd Logo
Supriya Lifescience Ltd
NSE:SUPRIYA
Watchlist
Price: 688.6 INR -2.55% Market Closed
Market Cap: 55.4B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+39%
Revenue
Forecast
+16%
Operating Income
Forecast
+22%
Net Income
Forecast
+41%

Wall Street
Price Targets

SUPRIYA Price Targets Summary
Supriya Lifescience Ltd

Wall Street analysts forecast SUPRIYA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SUPRIYA is 630.36 INR with a low forecast of 500.96 INR and a high forecast of 777 INR.

SUPRIYA Lowest Forecast
Wall Street Target
500.96 INR
27% Downside
SUPRIYA Average Forecast
Wall Street Target
630.36 INR
8% Downside
SUPRIYA Highest Forecast
Wall Street Target
777 INR
13% Upside
Lowest
Price Target
500.96 INR
27% Downside
Average
Price Target
630.36 INR
8% Downside
Highest
Price Target
777 INR
13% Upside
Supriya Lifescience Ltd Competitors:
Price Targets
C
2M7C
China Medical System Holdings Ltd
24% Upside
MARKSANS
Marksans Pharma Ltd
39% Upside
C
1093
CSPC Pharmaceutical Group Ltd
10% Upside
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
51% Upside
C
2M7C
China Medical System Holdings Ltd
24% Upside
MARKSANS
Marksans Pharma Ltd
39% Upside
C
1093
CSPC Pharmaceutical Group Ltd
10% Upside
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
51% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
36% Upside
E
EMCURE
Emcure Pharmaceuticals Ltd
52% Upside

Revenue
Forecast

Revenue Estimate
Supriya Lifescience Ltd

For the last 5 years the compound annual growth rate for Supriya Lifescience Ltd's revenue is 15%. The projected CAGR for the next 3 years is 23%.

15%
Past Growth
23%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Supriya Lifescience Ltd

For the last 5 years the compound annual growth rate for Supriya Lifescience Ltd's operating income is 22%. The projected CAGR for the next 3 years is 21%.

22%
Past Growth
21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Supriya Lifescience Ltd

For the last 5 years the compound annual growth rate for Supriya Lifescience Ltd's net income is 25%. The projected CAGR for the next 3 years is 24%.

25%
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
SUPRIYA intrinsic value, competitors valuation, and company profile.
DCF Valuation
SUPRIYA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SUPRIYA stock valuation using valuation multiples.
Wall Street Estimates
SUPRIYA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SUPRIYA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SUPRIYA's stock price target?
Price Target
630.36 INR

According to Wall Street analysts, the average 1-year price target for SUPRIYA is 630.36 INR with a low forecast of 500.96 INR and a high forecast of 777 INR.

What is Supriya Lifescience Ltd's Revenue forecast?
Projected CAGR
23%

For the last 5 years the compound annual growth rate for Supriya Lifescience Ltd's revenue is 15%. The projected CAGR for the next 3 years is 23%.

What is Supriya Lifescience Ltd's Operating Income forecast?
Projected CAGR
21%

For the last 5 years the compound annual growth rate for Supriya Lifescience Ltd's operating income is 22%. The projected CAGR for the next 3 years is 21%.

What is Supriya Lifescience Ltd's Net Income forecast?
Projected CAGR
24%

For the last 5 years the compound annual growth rate for Supriya Lifescience Ltd's net income is 25%. The projected CAGR for the next 3 years is 24%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 250,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.